Ella Instrument- Automated Immunoassay Machine acquisition

The National Institute of Neurological Disorders and Stroke within the National Institutes of Health is seeking to acquire a single Ella Automated Immunoassay System from Bio-Techne to advance its research into multiple sclerosis and related neuroinflammatory diseases. The system is critical for high-sensitivity, multiplexed quantification of key biomarkers such as neurofilament light chain and glial fibrillary acidic protein in minimal sample volumes of 25 μL, enabling rapid, reproducible results within 90 minutes without pipetting errors. This acquisition supports the Translational Neuroradiology Section’s mission to maintain scientific rigor and throughput in CNS research by replacing less reliable platforms with a fully automated, stable, and precise immunoassay system featuring a desktop unit, proprietary software suite, and a one-year warranty. Delivery is required within 30 days after receipt of order at the NINDS facility in Bethesda, Maryland, and no options or extended performance periods are anticipated. The solicitation, issued as a presolicitation under number 75N98026Q00510 on June 3, 2026, with a response deadline of June 8, 2026, is not set aside for any socioeconomic category and falls under NAICS code 334516 for medical equipment manufacturing. While the contract value, unit pricing, and payment details are not disclosed, the procurement is expected to be awarded based on best-value trade-off considerations due to the essential technical performance attributes required for high-impact neuroscience research. The equipment must meet specific operational criteria including parallel multi-analyte detection, a dynamic range of over four logs, and consistent analytical precision. No packaging, marking, inspection protocols, warranty clauses beyond the one-year term, or special contract requirements such as security clearances orOCI restrictions are specified. Proposals must be submitted by the stated deadline to the contracting office in Bethesda, though no electronic portal, format specifications, or submission instructions are provided. The point of contact for inquiries is Vishnuvajjala Hanumanth Rao at NIH/NINDS.